| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 2.08▼ | 2.08▲ | 2.08▼ | 2.09▼ | 2.34▼ |
| MA10 | 2.07▲ | 2.09▼ | 2.12▼ | 2.23▼ | 2.44▼ |
| MA20 | 2.08▲ | 2.14▼ | 2.14▼ | 2.41▼ | 3.12▼ |
| MA50 | 2.12▼ | 2.11▼ | 2.15▼ | 2.54▼ | 2.61▼ |
| MA100 | 2.17▼ | 2.19▼ | 2.37▼ | 3.09▼ | 4.43▼ |
| MA200 | 2.10▼ | 2.38▼ | 2.48▼ | 2.73▼ | 8.44▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.005▲ | -0.010▼ | -0.008▼ | -0.035▼ | -0.118▼ |
| RSI | 46.649▼ | 43.237▼ | 42.443▼ | 38.557▼ | 40.623▼ |
| STOCH | 95.556▲ | 31.628 | 18.593▼ | 14.839▼ | 16.958▼ |
| WILL %R | -25.000 | -72.727 | -81.250▼ | -88.772▼ | -94.495▼ |
| CCI | 39.822 | -59.123 | -84.499 | -82.104 | -117.609▼ |
|
Thursday, April 02, 2026 07:47 AM
Novartis AG (NYSE:NVS) is one of the best pharma stocks to invest in now. Novartis AG (NYSE:NVS) announced on March 29 the final two-year results from the Phase III APPLAUSE‑IgAN study of Fabhalta® in ...
|
|
Thursday, April 02, 2026 04:48 AM
Annovis Bio, Inc. (NYSE: ANVS) (“Annovis” or the “Company”), a Phase 3 clinical-stage biotechnology company developing the investigational oral therapy, buntanetap, for neurodegenerative diseases such ...
|
|
Tuesday, March 31, 2026 05:50 PM
In this article, we will look at the 7 Best Pharma Stocks to Invest In Now. On March 24, Scott Chronert, Citi, appeared on CNBC’s ‘Closing Bell’ to talk about the market and whether it is time to get ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 02/04/26 | 2.075 | 2.11 | 2.035 | 2.08 | 88,927 |
| 01/04/26 | 2.28 | 2.2899 | 2.00 | 2.12 | 475,542 |
| 31/03/26 | 2.03 | 2.26 | 2.03 | 2.23 | 467,054 |
| 30/03/26 | 2.03 | 2.05 | 1.96 | 2.01 | 352,578 |
| 27/03/26 | 2.15 | 2.16 | 1.975 | 2.03 | 718,383 |
| 26/03/26 | 2.20 | 2.24 | 2.12 | 2.15 | 424,229 |
| 25/03/26 | 2.40 | 2.4399 | 2.215 | 2.22 | 528,154 |
| 24/03/26 | 2.42 | 2.48 | 2.365 | 2.37 | 306,077 |
| 23/03/26 | 2.62 | 2.64 | 2.43 | 2.50 | 341,072 |
| 20/03/26 | 2.64 | 2.72 | 2.51 | 2.60 | 658,992 |
|
|
||||
|
|
||||
|
|